Sanofi (SNYNF) Equity Ratio (2009 - 2025)

Sanofi (SNYNF) has 17 years of Equity Ratio data on file, last reported at 0.56 in Q4 2025.

• Quarterly Equity Ratio fell 3.56% year-over-year to 0.56 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.56 (down 3.56% YoY) and the FY2025 annual result came in at 0.56, down 3.56% from the prior year.
• Equity Ratio was little changed at 0.56 in Q4 2025 per SNYNF's latest filing, from 0.56 in the prior quarter.
• The five-year high for Equity Ratio was 0.59 in Q4 2022, with the low at 0.56 in Q2 2025.
• Average Equity Ratio over 5 years is 0.57, with a median of 0.58 recorded in 2021.
• Year-over-year, Equity Ratio sank 98.55% in 2021 and rose 3.96% in 2022.
• Sanofi's Equity Ratio stood at 0.57 in 2021, then rose by 3.32% to 0.59 in 2022, then dropped by 0.79% to 0.59 in 2023, then decreased by 0.31% to 0.58 in 2024, then decreased by 3.56% to 0.56 in 2025.
• Business Quant data shows SNYNF's Equity Ratio at 0.56 in Q4 2025, 0.56 in Q2 2025, and 0.58 in Q4 2024.